Applications of the Stereoretentive O and C Rearrangemen
立体保留O和C重排的应用
基本信息
- 批准号:6931791
- 负责人:
- 金额:$ 2.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2006-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (provided by applicant) The overall goal of this research is to
develop stereoselective methods for the formation of sterically congested
carbon-carbon bonds in order to provide rapid, efficient, and selective routes
to biologically active molecules. These types of bonds are found in numerous
natural product targets. The structurally related class of tetramic acid
macrolactams, characterized by a polysubstituted bicyclo (3.3.0 core and a
tetramic acid moiety connected within a macrolactam, are accessible by this
methodology. They are of fundamental interest since members of this class
exhibit a diverse biological activity profile. Cylindramide exhibits
cytotoxicity against B16 melanoma cells. Geodin A is a potent nematocidal
agent. Alteramide A shows cytotoxicity against murine leukemia P388 cells,
murine lymphoma L1210 cells, and the human epidermoid carcinoma KB cells in
vitro. Discodermide inhibits the in vitro proliferation of cultured murine P388
leukemia cells and has some antifungal activity. Aburatubolactam A was found to
inhibit superoxide anion generation while aburatubolactam C induces apoptosis.
The central approach of this research is to convert chiral vinyl ethers into
the corresponding carbon-carbon bonds with retention of stereochemistry. This
strategy takes advantage of the multitude of ways to control carbon-oxygen bond
stereochemistry to translate it into carbon-carbon bond stereochemistry.
Specifically, the goals of this research are: 1) develop and explore the scope
of the stereoretentive O to C rearrangement of vinyl acetals; 2) apply this
insight to the development of a general vinyl ether O to C rearrangement and
investigate its limits; 3) explore new methods for the stereodefined generation
of vinyl ethers in order to expand the scope of the stereoretentive O to C
rearrangement of vinyl acetals and ethers; 4) extend these studies to the
stereoretentive replacement of chiral ethers with other nucleophiles; 5)
develop a mechanistic understanding of these reactions; 6) couple the
stereoretentive O to C rearrangement with a subsequent transformation to
facilitate the rapid assembly of oligopyrans relevant to the ladder toxin
family of natural products; 7) implement these methods in the stereoselective
synthesis of tetramic acid macrolactams such as cylindramide.
描述:(申请人提供)本研究的总体目标是
发展立体选择性方法形成立体充血
碳-碳键,以提供快速、高效和选择性的路线
到生物活性分子。这些类型的债券在许多
自然产品目标。结构上相关的四酸类化合物
大环内酰胺类,特征为多取代双环(3.3.0核心和
连接在大内酰胺中的四酸部分可通过以下方式访问
方法论。他们有根本的利益,因为这个班级的成员
展示不同的生物活动概况。环丙氨酰胺展品
对B16黑色素瘤细胞的细胞毒作用。Geodin A是一种有效的杀线虫药物
探员。Alteramide A对小鼠白血病P388细胞具有细胞毒作用,
小鼠淋巴瘤L1210细胞和人表皮样癌KB细胞
体外培养。迪可地胺抑制体外培养的小鼠P388细胞增殖
并具有一定的抗真菌活性。Aburatubolactam A被发现
抑制超氧阴离子的产生,而阿博拉坦C诱导细胞凋亡。
这项研究的中心方法是将手性乙烯基醚转化为
相应的具有立体化学保留的碳-碳键。这
战略利用多种方法来控制碳-氧键
将其转化为碳-碳键立体化学。
具体地说,本研究的目标是:1)开发和探索范围
乙烯缩醛的立体保留O到C重排;2)应用此
对一般乙烯基醚O-C重排反应发展的认识
调查它的局限性;3)探索新的方法,以适应刻板定义的一代
以扩大立体保留剂O到C的范围
乙烯缩醛和乙醚的重排;4)将这些研究扩展到
手性醚与其他亲核试剂的立体保留取代;5)
发展对这些反应的机械理解;6)将
立体保持O到C重排,随后转化为
促进与阶梯毒素相关的寡聚吡喃的快速组装
天然产物系列;7)将这些方法应用于立体选择性
圆柱胺等四酸大内酰胺类药物的合成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tomislav Rovis其他文献
Tomislav Rovis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tomislav Rovis', 18)}}的其他基金
A Tool for synthetic post-translational modifications of cysteines
半胱氨酸合成翻译后修饰的工具
- 批准号:
10378706 - 财政年份:2021
- 资助金额:
$ 2.41万 - 项目类别:
A Tool for synthetic post-translational modifications of cysteines
半胱氨酸合成翻译后修饰的工具
- 批准号:
10194719 - 财政年份:2021
- 资助金额:
$ 2.41万 - 项目类别:
Selective Functionalization of Aliphatic Amines and Derivatives
脂肪胺及其衍生物的选择性官能化
- 批准号:
9901587 - 财政年份:2017
- 资助金额:
$ 2.41万 - 项目类别:
Selective Functionalization of Aliphatic Amines and Derivatives
脂肪胺及其衍生物的选择性官能化
- 批准号:
9398254 - 财政年份:2017
- 资助金额:
$ 2.41万 - 项目类别:
Selective Functionalization of Aliphatic Amines - Supplement to Support Mariah Ramos
脂肪胺的选择性官能化 - 支持 Mariah Ramos 的补充
- 批准号:
10798989 - 财政年份:2017
- 资助金额:
$ 2.41万 - 项目类别:
相似海外基金
Nickel Cross-Coupling Cascades with α-Heteroatom Radicals to Prepare Sterically Hindered Alcohols and Amines
镍与α-杂原子自由基交叉偶联级联制备位阻醇和胺
- 批准号:
10604535 - 财政年份:2023
- 资助金额:
$ 2.41万 - 项目类别:
Application of the Diastereoselective Ketal Formation Reactions for the Organic Synthesis.
非对映选择性缩酮形成反应在有机合成中的应用。
- 批准号:
15K07872 - 财政年份:2015
- 资助金额:
$ 2.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Synthetic Studies Towards Periglaucines A, B, and Related Bioactive Hasubanans
Periglaucines A、B 和相关生物活性 Hasubanan 的合成研究
- 批准号:
8131386 - 财政年份:2011
- 资助金额:
$ 2.41万 - 项目类别:
Synthetic Studies Towards Periglaucines A, B, and Related Bioactive Hasubanans
Periglaucines A、B 和相关生物活性 Hasubanan 的合成研究
- 批准号:
8440392 - 财政年份:2011
- 资助金额:
$ 2.41万 - 项目类别:
Mixed-mode release kinetics of vascular endothelial growth factor and hepatocyte growth factor from an injectable poly(trimethylene carbonate-co-5-ethylene ketal-epsilon-caprolactone) delivery vehicle
可注射聚(三亚甲基碳酸酯-co-5-乙烯缩酮-ε-己内酯)递送载体中血管内皮生长因子和肝细胞生长因子的混合模式释放动力学
- 批准号:
408662-2011 - 财政年份:2011
- 资助金额:
$ 2.41万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Synthetic Studies Towards Periglaucines A, B, and Related Bioactive Hasubanans
Periglaucines A、B 和相关生物活性 Hasubanan 的合成研究
- 批准号:
8516064 - 财政年份:2011
- 资助金额:
$ 2.41万 - 项目类别:
Enhanced Fluoropolymer Membrane Reactors for Production of Pharmaceutical Interme
用于生产药物中间体的增强型含氟聚合物膜反应器
- 批准号:
8256745 - 财政年份:2011
- 资助金额:
$ 2.41万 - 项目类别:
Enhanced Fluoropolymer Membrane Reactors for Production of Pharmaceutical Interme
用于生产药物中间体的增强型含氟聚合物膜反应器
- 批准号:
8124389 - 财政年份:2011
- 资助金额:
$ 2.41万 - 项目类别:
Stereoselective Synthesis of Ketals using Thiourea-Based Catalysts
使用硫脲基催化剂立体选择性合成缩酮
- 批准号:
7998675 - 财政年份:2010
- 资助金额:
$ 2.41万 - 项目类别:
Total Synthesis of Bicyclic Bioactive Diterpenoids
双环生物活性二萜类化合物的全合成
- 批准号:
7933392 - 财政年份:2009
- 资助金额:
$ 2.41万 - 项目类别:














{{item.name}}会员




